Table of Contents

1 Study Coverage

• 1.1 Drug Delivery Devices Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Drug Delivery Devices Market Size Growth Rate by Product
  • 1.4.2 Injection type
  • 1.4.3 Mucosal type
  • 1.4.4 Implanted type
  • 1.4.5 Others type
• 1.5 Market by End User
  • 1.5.1 Global Drug Delivery Devices Market Size Growth Rate by End User
  • 1.5.2 Pharmaceutical companies
  • 1.5.3 Hospitals
  • 1.5.4 Clinics
  • 1.5.5 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Drug Delivery Devices Market Size
  • 2.1.1 Global Drug Delivery Devices Revenue 2014-2025
  • 2.1.2 Global Drug Delivery Devices Sales 2014-2025
• 2.2 Drug Delivery Devices Growth Rate by Regions
  • 2.2.1 Global Drug Delivery Devices Sales by Regions
  • 2.2.2 Global Drug Delivery Devices Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Drug Delivery Devices Sales by Manufacturers
  • 3.1.1 Drug Delivery Devices Sales by Manufacturers
  • 3.1.2 Drug Delivery Devices Sales Market Share by Manufacturers
  • 3.1.3 Global Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
• 3.2 Drug Delivery Devices Revenue by Manufacturers
  • 3.2.1 Drug Delivery Devices Revenue by Manufacturers (2014-2019)
  • 3.2.2 Drug Delivery Devices Revenue Share by Manufacturers (2014-2019)
• 3.3 Drug Delivery Devices Price by Manufacturers
• 3.4 Drug Delivery Devices Manufacturing Base Distribution, Product Types
  • 3.4.1 Drug Delivery Devices Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Drug Delivery Devices Product Type
  • 3.4.3 Date of International Manufacturers Enter into Drug Delivery Devices Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Drug Delivery Devices Sales by Product
• 4.2 Global Drug Delivery Devices Revenue by Product
• 4.3 Drug Delivery Devices Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Drug Delivery Devices Breakdown Data by End User

6 North America

• 6.1 North America Drug Delivery Devices by Countries
  • 6.1.1 North America Drug Delivery Devices Sales by Countries
  • 6.1.2 North America Drug Delivery Devices Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Drug Delivery Devices by Product
• 6.3 North America Drug Delivery Devices by End User

7 Europe

• 7.1 Europe Drug Delivery Devices by Countries
  • 7.1.1 Europe Drug Delivery Devices Sales by Countries
  • 7.1.2 Europe Drug Delivery Devices Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Drug Delivery Devices by Product
• 7.3 Europe Drug Delivery Devices by End User

8 Asia Pacific

• 8.1 Asia Pacific Drug Delivery Devices by Countries
  • 8.1.1 Asia Pacific Drug Delivery Devices Sales by Countries
  • 8.1.2 Asia Pacific Drug Delivery Devices Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Drug Delivery Devices by Product
• 8.3 Asia Pacific Drug Delivery Devices by End User

9 Central & South America

• 9.1 Central & South America Drug Delivery Devices by Countries
  • 9.1.1 Central & South America Drug Delivery Devices Sales by Countries
  • 9.1.2 Central & South America Drug Delivery Devices Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Drug Delivery Devices by Product
• 9.3 Central & South America Drug Delivery Devices by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Drug Delivery Devices by Countries
  • 10.1.1 Middle East and Africa Drug Delivery Devices Sales by Countries
  • 10.1.2 Middle East and Africa Drug Delivery Devices Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Drug Delivery Devices by Product
• 10.3 Middle East and Africa Drug Delivery Devices by End User

11 Company Profiles

• 11.1 Cipla
  • 11.1.1 Cipla Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Cipla Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Cipla Drug Delivery Devices Products Offered
  • 11.1.5 Cipla Recent Development
• 11.2 Baxter International
  • 11.2.1 Baxter International Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Baxter International Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Baxter International Drug Delivery Devices Products Offered
  • 11.2.5 Baxter International Recent Development
• 11.3 Nipro Corporation
  • 11.3.1 Nipro Corporation Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Nipro Corporation Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Nipro Corporation Drug Delivery Devices Products Offered
  • 11.3.5 Nipro Corporation Recent Development
• 11.4 Roche
  • 11.4.1 Roche Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Roche Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Roche Drug Delivery Devices Products Offered
  • 11.4.5 Roche Recent Development
• 11.5 Boehringer Ingelheim
  • 11.5.1 Boehringer Ingelheim Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Boehringer Ingelheim Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Boehringer Ingelheim Drug Delivery Devices Products Offered
  • 11.5.5 Boehringer Ingelheim Recent Development
• 11.6 Allergan
  • 11.6.1 Allergan Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Allergan Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Allergan Drug Delivery Devices Products Offered
  • 11.6.5 Allergan Recent Development
• 11.7 3M
  • 11.7.1 3M Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 3M Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 3M Drug Delivery Devices Products Offered
  • 11.7.5 3M Recent Development
• 11.8 BD
  • 11.8.1 BD Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 BD Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 BD Drug Delivery Devices Products Offered
  • 11.8.5 BD Recent Development
• 11.9 Catalent
  • 11.9.1 Catalent Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Catalent Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Catalent Drug Delivery Devices Products Offered
  • 11.9.5 Catalent Recent Development
• 11.10 Valeant Pharmaceuticals
  • 11.10.1 Valeant Pharmaceuticals Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Valeant Pharmaceuticals Drug Delivery Devices Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Valeant Pharmaceuticals Drug Delivery Devices Products Offered
  • 11.10.5 Valeant Pharmaceuticals Recent Development
• 11.11 Bayer AG
• 11.12 Chiesi
• 11.13 Phillips-Medisize
• 11.14 Johnson & Johnson
• 11.15 Shandong Weigao
• 11.16 Pfizer
• 11.17 B.Braun
• 11.18 Novartis AG
• 11.19 Zhengkang
• 11.20 Gerresheimer
• 11.21 COVIDIEN Medtronic
• 11.22 Schott forma vitrum
• 11.23 Alkermes
• 11.24 Skyepharma

12 Future Forecast

• 12.1 Drug Delivery Devices Market Forecast by Regions
  • 12.1.1 Global Drug Delivery Devices Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Drug Delivery Devices Revenue Forecast by Regions 2019-2025
• 12.2 Drug Delivery Devices Market Forecast by Product
  • 12.2.1 Global Drug Delivery Devices Sales Forecast by Product 2019-2025
  • 12.2.2 Global Drug Delivery Devices Revenue Forecast by Product 2019-2025
• 12.3 Drug Delivery Devices Market Forecast by End User
• 12.4 North America Drug Delivery Devices Forecast
• 12.5 Europe Drug Delivery Devices Forecast
• 12.6 Asia Pacific Drug Delivery Devices Forecast
• 12.7 Central & South America Drug Delivery Devices Forecast
• 12.8 Middle East and Africa Drug Delivery Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Drug Delivery Devices Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
By geographical region, the North American market was the largest in 2011. But, the report estimates that by nearly 2018, the share of North America in the drug delivery devices market will slide. The situation in the Asia Pacific will be quite the opposite, as the market in this region will witness accelerated growth on account of rapidly-emerging nations such as China.
In the future, China will be an important consumption market of drug delivery systems due to the fast growth of macro economy. With the rising of living standard, people will pay more and more attention on Healthcare, which urges the pharmaceutical companies develop related drugs, drive the development of drug delivery systems market. Briefly speaking, in the next few years, drug delivery devices industry will still be a highly energetic industry. Although sales of drug delivery devices brought a lot of opportunities, the study group recommends the new entrants who just having money but without technical advantage and downstream support, do not to enter into the drug delivery devices field hastily.

The global Drug Delivery Devices market is valued at 33900 million US$ in 2018 and will reach 49700 million US$ by the end of 2025, growing at a CAGR of 4.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Drug Delivery Devices market based on company, product type, end user and key regions.

This report studies the global market size of Drug Delivery Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drug Delivery Devices in these regions.
This research report categorizes the global Drug Delivery Devices market by top players/brands, region, type and end user. This report also studies the global Drug Delivery Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma

Market size by Product
Injection type
Mucosal type
Implanted type
Others type
Market size by End User
Pharmaceutical companies
Hospitals
Clinics
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Drug Delivery Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Drug Delivery Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Drug Delivery Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Drug Delivery Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Drug Delivery Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Drug Delivery Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.